 |
|
|
| |
EDP-297, a novel and potent fxr agonist, exhibit robust anti- fibrotic effects with significant liver function in a rat model of non-alcoholic steatohepatitis
|
| |
| |
EASL 2020 Aug 27-29 virtual
Reported by Jules Levin
Mozhdeh Sojoodi1, Yongtao Wang1, Derek J. Erstad1, Peter Caravan2, Michael Lanuti3, Motaz Qadan1, Bryan C. Fuchs1, Khanh Hoang4,
Yat Sun Or4, Lijuan Jiang4, Kenneth K. Tanabe1. 1Massachusetts General Hospital, Harvard Medical School, Surgical Oncology, Boston, United States; 2Massachusetts General Hospital, Harvard Medical School, The Institute for Innovation in Imaging, A. A. Martinos Center for Biomedical Imaging, Charlestown, United States; 3Massachusetts General Hospital, Harvard Medical School, Thoracic Surgery, Boston, United States; 4Enanta Pharmaceuticals, Inc, Watertown, United States
|
| |
|
|
|
|
|
